Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Sell
170,163
-238,319
-58% -$2.57M 0.03% 891
2026
Q1
$3.46M Buy
408,482
+325,027
+389% +$3.56M 0.06% 475
2025
Q4
$942K Buy
83,455
+19,816
+31% +$245K 0.02% 1065
2025
Q3
$955K Buy
+63,639
New +$926K 0.05% 602
2025
Q2
Sell
-37,446
Closed -$900K 2381
2025
Q1
$900K Buy
+37,446
New +$1.32M 0.05% 626
2024
Q4
Sell
-32,510
Closed -$1.62M 2309
2024
Q3
$1.62M Buy
32,510
+23,921
+279% +$931K 0.12% 212
2024
Q2
$298K Buy
8,589
+48
+0.6% +$1.9K 0.03% 969
2024
Q1
$467K Buy
+8,541
New +$423K 0.06% 526
2023
Q4
Sell
-12,997
Closed -$338K 1610
2023
Q3
$338K Sell
12,997
-1,675
-11% -$34.8K 0.06% 646
2023
Q2
$351K Buy
+14,672
New +$253K 0.06% 605

Other funds holding BHVN

XTX Topco's BHVN Position: Q2 2026 in Review

XTX Topco reduced its Biohaven (BHVN) stake by 58% in Q2 2026, selling an estimated $2.57M and leaving 170,163 shares worth $2.53M. The position accounts for 0.03% of the portfolio, ranked #891.

XTX Topco first reported a position in BHVN in Q2 2023 and has held it in 10 quarters since. The position peaked at $3.46M in Q1 2026. 294 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • XTX Topco held 170,163 shares of Biohaven worth $2.53M as of Q2 2026.
  • XTX Topco sold 238,319 Biohaven shares in Q2 2026, an estimated $2.57M.
  • Biohaven made up 0.03% of XTX Topco's portfolio in Q2 2026, its #891 holding.
  • XTX Topco first reported a position in Biohaven in Q2 2023 and has held it in 10 quarters since.
  • XTX Topco's Biohaven position peaked at $3.46M in Q1 2026.
  • 294 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.